![Mark Bishop](https://profiles-cardiff.imgix.net/attachments/927?w=200&h=200&auto=format&crop=faces&fit=crop&q=90")
Mr Mark Bishop
Technical Support Manager
School of Biosciences
- BishopM@cardiff.ac.uk
- +44 29206 88512
- Hadyn Ellis Building, Room European Cancer Stem Cell Research Institute, Cardiff School of Biosciences, Hadyn Ellis Building, Maindy Road, Cathays, Cardiff CF24 4HQ, Maindy Road, Cardiff, CF24 4HQ
Overview
Roles and Responsibilities
- Responsible for technical support, facilities and building infrastructure in ECSCRI, Hadyn Ellis Building.
- Training for Advanced Flow Cytometry / FACS and Confocal.
- Microscopy at ECSCRI.
- Responsible for ECSCRI deliveries.
Publication
2021
- Hrastelj, J. et al. 2021. CSF-resident CD4+ T-cells display a distinct gene expression profile with relevance to immune surveillance and multiple sclerosis. Brain Communications (10.1093/braincomms/fcab155)
2005
- Sansom, O. J., Bishop, S. M., Bird, A. and Clarke, A. R. 2005. MBD2 deficiency does not accelerate p53 mediated lymphomagenesis. Oncogene 24(14), pp. 2430-2432. (10.1038/sj.onc.1208166)
2004
- Sansom, O. J., Bishop, S. M., Bird, A. and Clarke, A. R. 2004. MBD4 deficiency does not increase mutation or accelerate tumorigenesis in mice lacking MMR. Oncogene 23(33), pp. 5693-5696. (10.1038/sj.onc.1207767)
2003
- Sansom, O. J., Bishop, S. M., Court, H., Dudley, S., Liskay, R. M. and Clarke, A. R. 2003. Apoptosis and mutation in the murine small intestine: loss of MIh1- and Pms2-dependent apoptosis leads to increased mutation in vivo. DNA Repair 2(9), pp. 1029-1039. (10.1016/S1568-7864(03)00111-3)
- Sansom, O. J., Zabkiewicz, J., Bishop, S. M., Guy, J., Bird, A. and Clarke, A. R. 2003. MBD4 deficiency reduces the apoptotic response to DNA-damaging agents in the murine small intestine. Oncogene 22(46), pp. 7130-7136. (10.1038/sj.onc.1206850)
- Sansom, O. J., Berger, J., Bishop, S. M., Hendrich, B., Bird, A. and Clarke, A. R. 2003. Deficiency of Mbd2 suppresses intestinal tumorigenesis. Nature Genetics 34(2), pp. 145-147. (10.1038/ng1155)
2002
- Millar, C. B. et al. 2002. Enhanced CpG Mutability and Tumorigenesis in MBD4-Deficient Mice. Science, pp. 403-405. (10.1126/science.1073354)
Articles
- Hrastelj, J. et al. 2021. CSF-resident CD4+ T-cells display a distinct gene expression profile with relevance to immune surveillance and multiple sclerosis. Brain Communications (10.1093/braincomms/fcab155)
- Sansom, O. J., Bishop, S. M., Bird, A. and Clarke, A. R. 2005. MBD2 deficiency does not accelerate p53 mediated lymphomagenesis. Oncogene 24(14), pp. 2430-2432. (10.1038/sj.onc.1208166)
- Sansom, O. J., Bishop, S. M., Bird, A. and Clarke, A. R. 2004. MBD4 deficiency does not increase mutation or accelerate tumorigenesis in mice lacking MMR. Oncogene 23(33), pp. 5693-5696. (10.1038/sj.onc.1207767)
- Sansom, O. J., Bishop, S. M., Court, H., Dudley, S., Liskay, R. M. and Clarke, A. R. 2003. Apoptosis and mutation in the murine small intestine: loss of MIh1- and Pms2-dependent apoptosis leads to increased mutation in vivo. DNA Repair 2(9), pp. 1029-1039. (10.1016/S1568-7864(03)00111-3)
- Sansom, O. J., Zabkiewicz, J., Bishop, S. M., Guy, J., Bird, A. and Clarke, A. R. 2003. MBD4 deficiency reduces the apoptotic response to DNA-damaging agents in the murine small intestine. Oncogene 22(46), pp. 7130-7136. (10.1038/sj.onc.1206850)
- Sansom, O. J., Berger, J., Bishop, S. M., Hendrich, B., Bird, A. and Clarke, A. R. 2003. Deficiency of Mbd2 suppresses intestinal tumorigenesis. Nature Genetics 34(2), pp. 145-147. (10.1038/ng1155)
- Millar, C. B. et al. 2002. Enhanced CpG Mutability and Tumorigenesis in MBD4-Deficient Mice. Science, pp. 403-405. (10.1126/science.1073354)